What We Do…
What we do is full-service early phase clinical research – just about every type of early phase testing you could possibly need: single ascending dose, multiple ascending dose, drug interaction, proof-of-concept, bioequivalence, cardiac safety, special populations and therapeutic sub specialties. We test large and small molecules, novel and generic compounds.
What we offer is the data you need to make critical go/no decisions when you need it. Fast, accurate data generated by selecting the most appropriate assay and bioanalytical technology, recruiting the most appropriate healthy and patient participants, and assigning the most experienced clinical teams, including physicians, nurses, scientists and project managers to your study.
We offer a rewarding experience. We’re easy to work with and flexible in meeting your needs.
